Since there is low expression of NAT16 in kidney, and high expression in endocrine tissues such as pancreas, it is likely that the increased risk of kidney disease observed for NAT16 (rs34985488-G) is caused by diminished acetylhistidine blood levels, not local acetylhistidine levels in kidney tissue or cells. Here, NAT16 is linked to kidney disorder.